Phathom Pharmaceuticals, Inc. entered into a Fourth Amendment to Loan and Security Agreement with Hercules Capital, Inc., increasing the aggregate principal amount of the term loans from $200,000,000 to $300,000,000 and extending the interest only period and maturity date.